Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ursina Wernli"'
Autor:
Chiara Jeiziner, Ursina Wernli, Katja Suter, Kurt E. Hersberger, Henriette E. Meyer zu Schwabedissen
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 5, Pp 1648-1658 (2021)
Abstract Alleles of the human leukocyte antigen (HLA) system have been associated with the occurrence of idiosyncratic adverse drug reactions (ADRs). Accordingly, it is assumed that pre‐emptive testing for the presence of certain HLA alleles (HLA
Externí odkaz:
https://doaj.org/article/f5f8be4aacb246fbb5a32f1400cb50fb
Autor:
Henriette E. Meyer zu Schwabedissen, Chiara Jeiziner, Kurt E. Hersberger, Ursina Wernli, Katja Suter
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 14, Iss 5, Pp 1648-1658 (2021)
Clinical and Translational Science, Vol 14, Iss 5, Pp 1648-1658 (2021)
Alleles of the human leukocyte antigen (HLA) system have been associated with the occurrence of idiosyncratic adverse drug reactions (ADRs). Accordingly, it is assumed that pre‐emptive testing for the presence of certain HLA alleles (HLA‐typing)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eed49fdb5714eb02b067274c24be3e1
https://doi.org/10.1111/cts.13062
https://doi.org/10.1111/cts.13062
Autor:
Ursina Wernli, Fabienne Dürr, Sibylle Jean-Petit-Matile, Andrea Kobleder, Carla Meyer-Massetti
BACKGROUND Subcutaneous drug administration is an interesting approach for symptom control in hospice and palliative care. However, most drugs have no marketing authorization for subcutaneous administration and are therefore used off-label. In order
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36e22dac9b4381ce3421ce6e9cb59e22
Autor:
Ursina Wernli, Désirée Hischier, Christoph R. Meier, Sibylle Jean-Petit-Matile, Alice Panchaud, Andrea Kobleder, Carla Meyer-Massetti
Publikováno v:
American Journal of Hospice and Palliative Medicine®. :104990912211307
Background In hospice and palliative care, drug therapy is essential for symptom control. However, drug regimens are complex and prone to drug-related problems. Drug regimens must be simplified to improve quality of life and reduce risks associated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606506421718c51957946659a08dd0ce
https://doi.org/10.1177/10499091221130758
https://doi.org/10.1177/10499091221130758